# | Title | Journal | Year | Citations |
---|
1 | Benign tumours of the bone: A review | Journal of Bone Oncology | 2015 | 185 |
2 | Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG | Journal of Bone Oncology | 2017 | 181 |
3 | Metastatic bone disease: Pathogenesis and therapeutic options | Journal of Bone Oncology | 2019 | 153 |
4 | The role of tumour-associated macrophages in bone metastasis | Journal of Bone Oncology | 2016 | 133 |
5 | Advances in immune checkpoint inhibitors for bone sarcoma therapy | Journal of Bone Oncology | 2019 | 122 |
6 | Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers | Journal of Bone Oncology | 2015 | 116 |
7 | Overexpression of lncRNA UCA1 promotes osteosarcoma progression and correlates with poor prognosis | Journal of Bone Oncology | 2016 | 96 |
8 | Myeloma bone disease: Pathophysiology and management | Journal of Bone Oncology | 2013 | 88 |
9 | Incidence, consequences and treatment of bone metastases in breast cancer patients—Experience from a single cancer centre | Journal of Bone Oncology | 2013 | 86 |
10 | The role of osteoblasts in bone metastasis | Journal of Bone Oncology | 2016 | 83 |
11 | Risk and clinicopathological features of osteosarcoma metastasis to the lung: A population-based study | Journal of Bone Oncology | 2019 | 83 |
12 | Incidence and consequences of bone metastases in lung cancer patients | Journal of Bone Oncology | 2013 | 78 |
13 | Advances in limb salvage treatment of osteosarcoma | Journal of Bone Oncology | 2018 | 75 |
14 | The role of osteoclasts in breast cancer bone metastasis | Journal of Bone Oncology | 2016 | 72 |
15 | miRNA-223 is a potential diagnostic and prognostic marker for osteosarcoma | Journal of Bone Oncology | 2016 | 71 |
16 | The role of biomarkers in the management of bone-homing malignancies | Journal of Bone Oncology | 2017 | 71 |
17 | Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04) | Journal of Bone Oncology | 2018 | 70 |
18 | The role of the bone microenvironment in skeletal metastasis | Journal of Bone Oncology | 2013 | 66 |
19 | The role of CXCR4 in multiple myeloma: Cells’ journey from bone marrow to beyond | Journal of Bone Oncology | 2019 | 66 |
20 | The role of 18F–NaF PET/CT in metastatic bone disease | Journal of Bone Oncology | 2015 | 64 |
21 | Blockade of CCL2 enhances immunotherapeutic effect of anti-PD1 in lung cancer | Journal of Bone Oncology | 2018 | 63 |
22 | The anti-tumour effects of zoledronic acid | Journal of Bone Oncology | 2014 | 62 |
23 | Bone metastases in thyroid cancer | Journal of Bone Oncology | 2020 | 59 |
24 | Role of autophagy in osteosarcoma | Journal of Bone Oncology | 2019 | 53 |
25 | A comparative study between limb-salvage and amputation for treating osteosarcoma | Journal of Bone Oncology | 2016 | 52 |
26 | The bone metastasis niche in breast cancer: potential overlap with the haematopoietic stem cell niche in vivo | Journal of Bone Oncology | 2019 | 52 |
27 | Hypoxia-induced autophagy as an additional mechanism in human osteosarcoma radioresistance | Journal of Bone Oncology | 2016 | 50 |
28 | Incidence, risk factors and prognostic characteristics of bone metastases and skeletal-related events (SREs) in breast cancer patients: A systematic review of the real world data | Journal of Bone Oncology | 2018 | 48 |
29 | A definition of “uncomplicated bone metastases” based on previous bone metastases radiation trials comparing single-fraction and multi-fraction radiation therapy | Journal of Bone Oncology | 2015 | 47 |
30 | RANK and RANK ligand expression in primary human osteosarcoma | Journal of Bone Oncology | 2015 | 47 |
31 | Quality of life after palliative radiotherapy in bone metastases: A literature review | Journal of Bone Oncology | 2015 | 46 |
32 | Application of 3D-printed PEEK scapula prosthesis in the treatment of scapular benign fibrous histiocytoma: A case report | Journal of Bone Oncology | 2018 | 46 |
33 | Separation surgery for metastatic epidural spinal cord compression: A qualitative review | Journal of Bone Oncology | 2020 | 43 |
34 | Surface osteosarcoma: Clinical features and therapeutic implications | Journal of Bone Oncology | 2015 | 41 |
35 | Incidence of pain flare in radiation treatment of bone metastases: A literature review | Journal of Bone Oncology | 2014 | 40 |
36 | Health resource utilization associated with skeletal-related events in patients with bone metastases: Results from a multinational retrospective – prospective observational study – a cohort from 4 European countries | Journal of Bone Oncology | 2014 | 40 |
37 | Exosomes derived from bone marrow mesenchymal stem cells promote osteosarcoma development by activating oncogenic autophagy | Journal of Bone Oncology | 2020 | 40 |
38 | Limb-salvage surgery offers better five-year survival rate than amputation in patients with limb osteosarcoma treated with neoadjuvant chemotherapy. A systematic review and meta-analysis | Journal of Bone Oncology | 2020 | 39 |
39 | Prognostic factors in osteosarcoma: A study level meta-analysis and systematic review of current practice | Journal of Bone Oncology | 2020 | 39 |
40 | Radiomics signature extracted from diffusion-weighted magnetic resonance imaging predicts outcomes in osteosarcoma | Journal of Bone Oncology | 2019 | 38 |
41 | Aneurysmal bone cyst: A review of 65 patients | Journal of Bone Oncology | 2019 | 37 |
42 | Long noncoding RNA UCA1 promotes osteosarcoma metastasis through CREB1-mediated epithelial-mesenchymal transition and activating PI3K/AKT/mTOR pathway | Journal of Bone Oncology | 2019 | 37 |
43 | Epidemiology of spinal metastases, metastatic epidural spinal cord compression and pathologic vertebral compression fractures in patients with solid tumors: A systematic review | Journal of Bone Oncology | 2022 | 37 |
44 | New perspective into mesenchymal stem cells: Molecular mechanisms regulating osteosarcoma | Journal of Bone Oncology | 2021 | 36 |
45 | Possible survival benefits from zoledronic acid treatment in patients with bone metastases from solid tumours and poor prognostic features—An exploratory analysis of placebo-controlled trials | Journal of Bone Oncology | 2013 | 34 |
46 | Vascular niches for disseminated tumour cells in bone | Journal of Bone Oncology | 2016 | 34 |
47 | Prognostic nomograms for predicting overall and cancer-specific survival of high-grade osteosarcoma patients | Journal of Bone Oncology | 2018 | 34 |
48 | The role of bone marrow adipocytes in bone metastasis | Journal of Bone Oncology | 2016 | 33 |
49 | Osteochondroma: Review of 431 patients from one medical institution in South China | Journal of Bone Oncology | 2017 | 33 |
50 | The role of microRNAs in bone metastasis | Journal of Bone Oncology | 2016 | 32 |